Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LGC is a leading global life sciences tools company providing mission-critical components and solutions to the healthcare, applied research, and food safety markets. The company operates through several specialized divisions, including Genomics (under the Biosearch Technologies brand), Standards, and Clinical Diagnostics, which includes well-known brands like SeraCare and Maine Standards. LGC provides a wide array of products such as reference materials, oligonucleotides, PCR reagents, and proficiency testing services essential for drug discovery and clinical diagnostics. In 2020, the company was acquired by a consortium led by private equity firms Cinven and Astorg through the investment vehicle Pegasus Bidco Limited. LGC also serves as the UK's National Measurement Laboratory for chemical and bio-measurement, maintaining a unique role in global scientific standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pegasus Bidco.